Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya

[1] Garland SM(2007)Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 1928-1943

[2] Hernandez-Avila M(2007)Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 1915-1927

[3] Wheeler CM(2009)Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Lancet 374 301-314

[4] Perez G(2009)Human papillomavirus vaccines: WHO position paper WHO Weekly Epidemiol Record 84 118-139

[5] Harper DM(2006)Chapter 15: HPV vaccine use in the developing world Vaccine S3 132-218

[6] Leodolter S(2006)Chapter 25: Education, training, and communication for HPV vaccines Vaccine 24 210-4867

[7] Tang GWK(2010)HPV vaccine acceptability among Kenyan women Vaccine 28 4864-461

[8] Ferris DG(2009)Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings Arch Pediatr Adolesc Med 163 455-13

[9] Steben M(2005)Mapping the process: An exemplar of process and challenge in grounded theory analysis Educ Res 34 3-155

[10] Bryan J(2011)Developing and using a codebook for the analysis of interview data: An example from a professional development research project Field Methods 23 136-172

[1] Garland SM(2007)Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 1928-1943

[2] Hernandez-Avila M(2007)Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 1915-1927

[3] Wheeler CM(2009)Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Lancet 374 301-314

[4] Perez G(2009)Human papillomavirus vaccines: WHO position paper WHO Weekly Epidemiol Record 84 118-139

[5] Harper DM(2006)Chapter 15: HPV vaccine use in the developing world Vaccine S3 132-218

[6] Leodolter S(2006)Chapter 25: Education, training, and communication for HPV vaccines Vaccine 24 210-4867

[7] Tang GWK(2010)HPV vaccine acceptability among Kenyan women Vaccine 28 4864-461

[8] Ferris DG(2009)Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings Arch Pediatr Adolesc Med 163 455-13

[9] Steben M(2005)Mapping the process: An exemplar of process and challenge in grounded theory analysis Educ Res 34 3-155

[10] Bryan J(2011)Developing and using a codebook for the analysis of interview data: An example from a professional development research project Field Methods 23 136-172